BR9307347A - Derivados de 5-hidrazino-quinolina antimicrobianos - Google Patents

Derivados de 5-hidrazino-quinolina antimicrobianos

Info

Publication number
BR9307347A
BR9307347A BR9307347A BR9307347A BR9307347A BR 9307347 A BR9307347 A BR 9307347A BR 9307347 A BR9307347 A BR 9307347A BR 9307347 A BR9307347 A BR 9307347A BR 9307347 A BR9307347 A BR 9307347A
Authority
BR
Brazil
Prior art keywords
hydrazino
antimicrobial
quinoline derivatives
quinoline
derivatives
Prior art date
Application number
BR9307347A
Other languages
English (en)
Inventor
Thomas Prosser Demuth
Ronald Eugene White
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR9307347A publication Critical patent/BR9307347A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
BR9307347A 1992-10-30 1993-10-22 Derivados de 5-hidrazino-quinolina antimicrobianos BR9307347A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96896092A 1992-10-30 1992-10-30
PCT/US1993/010091 WO1994010163A1 (en) 1992-10-30 1993-10-22 Antimicrobial 5-hydrazino-quinolone derivatives

Publications (1)

Publication Number Publication Date
BR9307347A true BR9307347A (pt) 1999-05-25

Family

ID=25514997

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9307347A BR9307347A (pt) 1992-10-30 1993-10-22 Derivados de 5-hidrazino-quinolina antimicrobianos

Country Status (21)

Country Link
EP (1) EP0666853A1 (pt)
JP (1) JPH08502750A (pt)
KR (1) KR950704301A (pt)
CN (1) CN1064357C (pt)
AU (1) AU687018B2 (pt)
BR (1) BR9307347A (pt)
CA (1) CA2148003A1 (pt)
CZ (1) CZ282581B6 (pt)
EG (1) EG20543A (pt)
FI (1) FI952049A (pt)
HU (1) HUT72072A (pt)
IL (1) IL107323A (pt)
MX (1) MX9306814A (pt)
NO (1) NO951640L (pt)
NZ (1) NZ257470A (pt)
PL (1) PL178094B1 (pt)
RU (1) RU2126000C1 (pt)
SG (1) SG59979A1 (pt)
SK (1) SK54795A3 (pt)
WO (1) WO1994010163A1 (pt)
ZA (1) ZA938089B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646163A (en) * 1992-10-30 1997-07-08 The Procter & Gamble Company Quinolone 5-(N-heterosubstituted amino) antimicrobials
ATE190972T1 (de) * 1994-08-02 2000-04-15 Procter & Gamble Verfahren zur herstellung von antimikrobiellen verbindungen
EP0775145A1 (en) * 1994-08-02 1997-05-28 The Procter & Gamble Company Process for making quinolonyl lactam antimicrobials and novel intermediate compounds
CA2242242C (en) * 1996-02-09 2001-08-07 Toyama Chemical Co., Ltd. Quinolonecarboxylic acid derivatives or salts thereof
US8524734B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
PT1901749T (pt) * 2005-05-18 2016-11-04 Raptor Pharmaceuticals Inc Fluoroquinolonas aerossolizadas e suas utilizações
EE05697B1 (et) 2005-06-08 2014-02-17 Janssen Pharmaceutica N.V. Kinoliini derivaadid kui antibakteriaalsed toimeained
EA010601B1 (ru) * 2005-06-09 2008-10-30 Янссен Фармацевтика Н.В. Производные хинолина в качестве антибактериальных агентов
CN101020647B (zh) * 2007-02-14 2011-03-30 杭州师范学院 一种β-环丙胺基丙烯酸(酯)的合成方法
US8063066B2 (en) 2007-03-19 2011-11-22 Takeda Pharmaceutical Company Limited MAPK/ERK kinase inhibitors
DK3092901T3 (da) * 2007-10-05 2020-05-18 Senhwa Biosciences Inc Quinolonanaloger og fremgangsmåder relateret dertil
MX2010012855A (es) * 2008-06-03 2010-12-21 Actelion Pharmaceuticals Ltd Derivados de [4-(1-amino-etil)-ciclohexil]-metil-amina y [6-(1-amino-etil)-tetrahidro-piran-3-il]-metil-amina como antibacterianos.
ES2809177T3 (es) 2008-10-07 2021-03-03 Horizon Orphan Llc Inhalación de levofloxacino para reducir la inflamación pulmonar
JP2012505223A (ja) 2008-10-07 2012-03-01 エムペックス・ファーマシューティカルズ・インコーポレーテッド 薬物動態の改善のためのエアゾールフルオロキノロン配合物
AR076222A1 (es) * 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen
CA2773033C (en) 2009-09-04 2016-10-11 Mpex Pharmaceuticals, Inc. Use of aerosolized levofloxacin for treating cystic fibrosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668680A (en) * 1985-12-12 1987-05-26 Warner-Lambert Company 5-amino-6,8-difluoroquinolones as antibacterial agents
JPH0228178A (ja) * 1988-04-23 1990-01-30 Toyama Chem Co Ltd 新規なピリドンカルボン酸誘導体およびその塩並びにそれらの製造法
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
IE66202B1 (en) * 1989-08-16 1995-12-13 Pfizer Azabicyclo quinolone carboxylic acids
JPH05506033A (ja) * 1990-04-18 1993-09-02 ノーウィッチ、イートン、ファーマスーティカルズ、インコーポレーテッド 抗微生物性キノロニルラクタム類
WO1992009596A1 (en) * 1990-11-30 1992-06-11 Warner-Lambert Company Individual stereoisomers of 7-[3-(1-aminoalkyl)-1-pyrrolidinyl]-quinolones and naphthyridones as antibacterial agents

Also Published As

Publication number Publication date
MX9306814A (es) 1994-07-29
CA2148003A1 (en) 1994-05-11
ZA938089B (en) 1994-06-07
SK54795A3 (en) 1995-12-06
HUT72072A (en) 1996-03-28
PL178094B1 (pl) 2000-02-29
NZ257470A (en) 1997-08-22
EG20543A (en) 1999-07-31
KR950704301A (ko) 1995-11-17
NO951640D0 (no) 1995-04-28
AU687018B2 (en) 1998-02-19
SG59979A1 (en) 1999-02-22
IL107323A (en) 2000-06-01
FI952049A0 (fi) 1995-04-28
RU95110762A (ru) 1997-01-10
CN1064357C (zh) 2001-04-11
JPH08502750A (ja) 1996-03-26
NO951640L (no) 1995-06-30
IL107323A0 (en) 1994-01-25
WO1994010163A1 (en) 1994-05-11
FI952049A (fi) 1995-04-28
CN1092773A (zh) 1994-09-28
EP0666853A1 (en) 1995-08-16
HU9501237D0 (en) 1995-06-28
RU2126000C1 (ru) 1999-02-10
CZ282581B6 (cs) 1997-08-13
CZ109795A3 (en) 1995-12-13
AU5409794A (en) 1994-05-24
PL308671A1 (en) 1995-08-21

Similar Documents

Publication Publication Date Title
ATA75293A (de) Indolderivate
DE59309028D1 (de) Viruswirksame desinfektionsmittel
NL300035I1 (nl) Gesubstitueerde thiahzolidinedionderivaten.
NO924000D0 (no) Antimikrobielle kinolontiourea-forbindelser
NO920103L (no) Antibakterielle midler
DE69330497D1 (de) Chinazolin-derivate
KR950700911A (ko) 살균약제로서의 치환된 3-피롤리디닐티오-카르바페넴(Substituted 3-Pyrrolidinylthio-Carbapenems as Antimicrobial Agents)
BR9307347A (pt) Derivados de 5-hidrazino-quinolina antimicrobianos
DE59308714D1 (de) Cyclobutan-benzol-derivate
AT399443B (de) Sportschuh
ATE172738T1 (de) Substituierte 6-aza-androstenone
FI952804A (fi) Substituoidut bentsatsepinonit
NO952288D0 (no) Benzazepinon-derivater
DE69313890D1 (de) 5-Aminoflavon-Derivate
MX9206710A (es) Derivados de piridinol
DE59309389D1 (de) Substituierte Thiophencarbonsäureamide
ATA151292A (de) Beschlag
BR9104543A (pt) Derivados de triazolpiridazina
ATA227792A (de) Sportschuh
PT101252A (pt) Derivados de piridona-azetidinilo substituidos com actividade antimicrobiana
NO932638D0 (no) 21-klor-pregnanderivat
DE59310082D1 (de) Substituierte 2-arylpyrrole
BR9306708A (pt) Microbicidas
ATA151392A (de) Beschlag
KR940000046U (ko) 낚시찌

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
FC Decision: refusal
FC Decision: refusal
CKFC Appeal: appeal against refusal